The ADAPTation to Therapeutic Resistance Training (ADAPT) Study

January 30, 2023 updated by: Peter Ladlow, Defence Medical Rehabilitation Centre, UK

Low-load Blood Flow Restriction Exercise Versus Conventional Heavier Load Resistance Training Exercise in UK Military Personnel With Persistent Knee Pain: A Multi-centre Randomized Controlled Trial

In 2018, the Academic Department of Military Rehabilitation (ADMR) published a pilot randomised controlled trial (RCT), demonstrating the feasibility and acceptability of integrating twice-daily blood flow restriction (BFR) training into a busy residential care setting. Following its publication was a guidance note written by the Directorate of Defence Rehabilitation restricting the implementation of BFR training until more evidence can be provided to support its efficacy. This research trial is a fully-powered, multi-centre RCT investigating the efficacy and biological mechanism underpinning BFR therapy in UK military personnel with lower-limb musculoskeletal injury (specifically, persistent anterior knee pain) during residential rehabilitation. This study will aim to optimise both the rehabilitation outcome and improve the time-and cost-effectiveness of the service delivered across UK Defence Rehabilitation and beyond. Results will provide insight and knowledge to the clinical and scientific community to not only those embedded within Defence Rehabilitation, but also those working in civilian sector organisations and professional sport in the UK and abroad.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Aldershot, United Kingdom
        • Recruiting
        • RRU Aldershot
        • Contact:
          • Ollie Rosenstock
      • Colchester, United Kingdom
        • Recruiting
        • RRU Colchester
        • Contact:
          • Rachel Spanner
      • Cranwell, United Kingdom
        • Recruiting
        • RRU Cranwell
      • Edinburgh, United Kingdom
        • Recruiting
        • RRU Edinburgh
        • Contact:
          • Gordon McKay
      • St Athan, United Kingdom
        • Recruiting
        • RRU St Athan
      • Tidworth, United Kingdom
        • Recruiting
        • RRU Bulford
        • Contact:
          • Alice Essam

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • mechanical knee pain for at least three months
  • present with clinical signs and symptoms of knee pain arising from the tibiofemoral or patellofemoral joint diagnosed by sport and exercise medicine physician and/or physiotherapist
  • have reduced occupational employability medical grade secondary to their knee pain
  • report progression of resistance training load within the patient's rehabilitation programme is limited by knee pain
  • aged between 18 and 55 years
  • available to attend for the entire duration of the RRU course and a review appointment 3-months following course.

Exclusion Criteria:

diagnosed tibial, femoral or patella fracture and/or dislocation;

  • present with instability in the knee resulting from ligament deficiency
  • present with clinical signs and symptoms of patellar tendinopathy
  • have planned surgery over the study period
  • restricted knee range of movement; clinical signs and symptoms of non-musculoskeletal or serious pathological condition (i.e. Inflammatory arthropathy, infection or tumour) or referred pain from non-local pain source
  • present with any physical impairment or co-morbidities (including cardio-vascular disease) precluding the safe participation in the rehabilitation programme and/or assessment procedures
  • Cortico-steroid or analgesic injection intervention within the previous 7-days or previous knee surgery within the last 12 months to the affected limb

Medical Exclusion Criteria:

  • History of cardiovascular disease including hypertension, peripheral vascular disease, thrombosis/embolism, ischaemic heart disease, myocardial infarction.
  • History of the following musculoskeletal disorders: rheumatoid arthritis, avascular necrosis or osteonecrosis, severe osteoarthritis.
  • History of the following neurological disorders: Peripheral neuropathy, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, severe traumatic brain injury.
  • Varicose veins in the lower limb
  • Acute viral or bacterial upper or lower respiratory infection at screening
  • Known or suspected lower limb chronic exertional compartment syndrome (CECS)
  • Postsurgical swelling
  • Surgical insertion of metal components at the position of cuff inflation
  • History of any of the following conditions or disorders not previously listed: diabetes, active cancer
  • History of elevated risk of unexplained fainting or dizzy spells during physical activity/exercise that causes loss of balance
  • History of haemorrhagic stroke or exercise induced rhabdomyolysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Low-load blood flow restriction training (LL-BFR)
Twice daily LL-BFR for 3 weeks
Comparing two different exercise-based treatment methodologies on the clinical outcomes of individuals with persistent knee pain.
ACTIVE_COMPARATOR: Heavier load resistance training (HL-RT)
Three sessions per week for 3 weeks
Comparing two different exercise-based treatment methodologies on the clinical outcomes of individuals with persistent knee pain.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Lower Extremity Functional Scale (LEFS) over time
Time Frame: Baseline, week 3 and week 15
LEFS is a 20-question patient-reported outcome measure (PROM) that measures functional status in patients with lower limb musculoskeletal injury. Questions on activity vary in physical demand from walking to running on uneven ground. The LEFS is a validated tool and has demonstrated good test-retest reliability and responsiveness in individuals with persistent knee pain.
Baseline, week 3 and week 15

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in Patient Specific Functional Scale over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in Musculoskeletal Health Questionnaire (MSK-HQ) over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in Tampa Scale of Kinesiophobia (TSK) over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Health Anxiety Depression Scale (HADS)
Time Frame: Baseline
Baseline
Change in International Physical Activity Questionnaire (IPAQ) over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in Numeric Pain Rating Scale (NPRS) over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in Sport Injury Rehabilitation Beliefs Survey (SIRBS) over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in functional Activity Assessment (FAA) over time
Time Frame: Baseline and week 15
Baseline and week 15
Change in five Repetition Maximum Leg Press over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in isometric muscle strength of hip and knee using hand-held dynamometer over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in single leg heel raises to fatigue over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in qualitative assessment of single leg squat (QASLS) over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in decline knee bend over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in isometric midthigh pull over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in counter-movement jump over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in knee extension and flexion - maximal isometric voluntary contraction over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in muscle volume and anatomical cross sectional area (CSA) using magnetic resonance imaging (MRI) over time
Time Frame: Baseline, week 3 and week 15
Baseline, week 3 and week 15
Change in pennation angle over time using ultrasonography
Time Frame: Baseline, week 3 and week 15
Pennation angle measured in degrees
Baseline, week 3 and week 15
Change in fascicle length over time using ultrasonography
Time Frame: Baseline, week 3 and week 15
fascicle length measured in mm
Baseline, week 3 and week 15
Change in single leg squat over time - kinetic and kinematic analysis
Time Frame: Baseline, week 3 and week 15
3D motion capture and force plate data will be used to collect kinetic and kinematic data which will be later analysed using inverse dynamics. Force measured in Newtons, Moments measured in Newton/Metres/kg
Baseline, week 3 and week 15
Change in bilateral squat over time - kinetic and kinematic analysis
Time Frame: Baseline, week 3 and week 15
3D motion capture and force plate data will be used to collect kinetic and kinematic data which will be later analysed using inverse dynamics. Force measured in Newtons, Moments measured in Newton/Metres/kg
Baseline, week 3 and week 15
Change in markers of muscle damage over time
Time Frame: Baseline, week 3 and week 15
Using fasted blood samples. E.g., Creatine Kinase (units/L)
Baseline, week 3 and week 15
Change in markers of oxidative stress over time
Time Frame: Baseline, week 3 and week 15
Using fasted blood samples. E.g., Protein carbonyl (units/L)
Baseline, week 3 and week 15
Change in markers of inflammation over time
Time Frame: Baseline, week 3 and week 15
Using fasted blood samples. E.g., Interleukin-6 (pg/ml)
Baseline, week 3 and week 15
Change in markers of endothelial function over time
Time Frame: Baseline, week 3 and week 15
Using fasted blood samples. E.g., Vascular endothelial growth factor (µg/L)
Baseline, week 3 and week 15
Change in daily monitoring of wellness score over time
Time Frame: Daily for the 3 weeks of rehabilitation
Subjective patient reported outcome measure of 'wellness' scored using a 5-point likert scale.
Daily for the 3 weeks of rehabilitation
Change in daily monitoring of session rate of perceived exertion (sRPE) over time
Time Frame: Daily for the 3 weeks of rehabilitation
Subjective patient reported outcome measure of exertion, scored 0 to 10 (0 = no exertion, 10= maximal exertion)
Daily for the 3 weeks of rehabilitation
Change in daily monitoring of pain over time
Time Frame: Daily for the 3 weeks of rehabilitation
Subjective patient reported outcome measure of pain measured using a 0 to 100mm visual analog scale (VAS). 0= no pain, 100 = worst pain
Daily for the 3 weeks of rehabilitation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Alexander Bennett, PhD, Defence Medical Rehabilitation Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2022

Primary Completion (ANTICIPATED)

August 31, 2024

Study Completion (ANTICIPATED)

August 31, 2024

Study Registration Dates

First Submitted

January 19, 2023

First Submitted That Met QC Criteria

January 30, 2023

First Posted (ESTIMATE)

February 9, 2023

Study Record Updates

Last Update Posted (ESTIMATE)

February 9, 2023

Last Update Submitted That Met QC Criteria

January 30, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Anonymised participant data will be made available upon reasonable request to the chief investigator.

IPD Sharing Time Frame

Upon completion of the dissemination of research findings (i.e, publications and conference proceedings)

IPD Sharing Access Criteria

Most data will be openly available but, due to privacy concerns, some data regarding participants are available only to bona fide researchers working on a related project, subject to the completion of a non-disclosure agreement.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Weakness

Clinical Trials on Resistance Training

Subscribe